United States

Back to map

Showing 91-100 of 333 grants

Title Institution Researcher Program Duration Total Award Amount
SOLUBLE LYMPHOCYTE ACTIVATION GENE-3 (s-LAG-3): A POTENTIAL SURROGATE MARKER FOR TYPE-1 DIABETES PROGRESSION AND IMMUNOTHERAPY SUCCESS Trustees of Indiana University Jon Piganelli Cures 01-July-2025 to 30-June-2026 $153,000.00
Investigating Combinatorial Use of Inhibitors of Focal Adhesion Kinase and PFKFB3 for Reversal of Type 1 Diabetes Trustees of Indiana University Jon Piganelli Cures 01-August-2023 to 30-June-2025 $334,595.29
Safety and Efficacy of Adjunct Therapies in Adults with Type 1 diabetes: multicenter, registry-based study Trustees of Indiana University Viral Shah Improving Lives 01-September-2025 to 31-August-2028 $1,603,777.39
Relationship of Time-In-Range with microvascular complications in type 1 diabetes Trustees of Indiana University Viral Shah Improving Lives 01-February-2024 to 31-July-2025 $71,123.95
CGM-Derived Glucose Dynamic Index as Diagnostic Marker for Progression to Type 1 Diabetes Trustees of Indiana University Viral Shah Cures 01-November-2024 to 31-October-2027 $900,000.00
Achieving persistent presentation of self-antigens to reestablish tolerance and prevent autoimmune diabetes Trustees of Columbia University in the City of New York Camillo Bechi Genzano Cures 01-March-2025 to 29-February-2028 $256,285.00
Improving pig islet transplant efficacy in a preclinical baboon diabetes model with induced immune tolerance to the xenografts Trustees of Columbia University in the City of New York Megan Sykes Cures 01-June-2024 to 31-May-2026 $599,999.94
Low level engraftment of modified HSCs for continuous and omnipresent autoantigen exposure as requirements to establish tolerance Trustees of Columbia University in the City of New York Remi Creusot Cures 01-June-2024 to 31-January-2026 $188,704.16
In vivo analysis of human islet graft infiltration and its immunomodulation by antigen-specific therapy Trustees of Columbia University in the City of New York Remi Creusot Cures 01-August-2022 to 31-July-2025 $699,997.82
Development of Low Cost, High Precision Nano Pumps for Insulin Delivery Torramics Inc. Sergey Gimelshein Improving Lives 01-March-2023 to 31-August-2025 $1,493,212.43